Business Focus
Clinical Focus
Spotlight
Academy
CME/CE
Job Board
Subscribe
- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
The future of COVID-19 testing
What the BA.2 variant, the ending of mask mandates and allergy season means for COVID-19 testing.
COVID-19 is on the rise again. At the same time many mask and social distancing mandates are ending. And, lastly, allergy season is upon us, which means many of your patients may be unsure if they have COVID-19 or allergy symptoms.
To discuss these trends, Medical Economics sat down with Joseph Mann, MSN, FNP-C, of BD Life Sciences. Watch the interview below.
Related Videos
Related Content
